 BURBANK, Calif., Oct. 06, 2021 GLOBE NEWSWIRE -- via NewMediaWire Medolife Rx, Inc. Medolife, a global integrated biopharmaceutical company with RD, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. OTCQB: QNTA, announced today that it has initiated a study on its polarized cannabidiol CBD muscle rub product, sold under the brand Aelia. The study will analyze the effectiveness of the product in reducing inflammation through the inhibition of cyclooxygenase-2 COX-2 enzyme activity in the human body and compare the findings with other non-polarized CBD products currently available on the market. 